Study of the protective effect of total flavonoids of Dracocephalum moldavica L.On doxorubicin induced injury in HUVECs based on VEGF-B/AMPKa pathway
- Author:
Shao-Jiang LI
1
;
Wen-Ling SU
2
;
Di-Wei LIU
2
;
Rui-Fang ZHENG
2
;
Wen-Ling SU
3
;
Lei XU
3
;
Rui-Fang ZHENG
3
;
Jian-Guo XING
3
;
Zhi-Jian LI
4
Author Information
- Publication Type:Journal Article
- Keywords: cardiotoxicity; doxorubicin; endothelial dysfunction; human umbilical vein endothelial cells; total flavonoids of Dracocephalum mold- avica L.; vascular endothelial growth factor B
- From: Chinese Pharmacological Bulletin 2022;38(5):726-732
- CountryChina
- Language:Chinese
- Abstract: Aim To investigate the protective effect of TFDM on doxorubicin-induced endothelial cell injury and its mechanism.Methods Cell viability was detected by CCK-8 assay.Cell morphology was observed by microscope.The changes of LDH, SOD and mitochondrial membrane potential were detected by kit method.Cell migration was detected by Transwell assay; Endothelial dysfunction and VEGF-B/AMPKa pathway related protein expression were detected by Western blot.Results Compared with model group, TFDM significantly increased cell viability, improved the morphologic changes of HUVEC induced by DOX, decreased LDH leakage, increased SOD activity, increased mitochondrial membrane potential, promoted endothelial cell migration, and inhibited endothelial cell injury.The results of Western blot showed that com pared with control group TFDM increased the expression levels of non-receptor tyrosine kinase ( Src) and focal adhesion kinase (FAK) .increased the phosphorylation level of eNOS, and decreased the expression level of ET-1 protein, thereby inhibiting endothelial dysfunction.The protein expression levels of VEGF-B, NRP1 , VEGFR1 and the ratio of p-AMPKa/AMPKa significantly increased in the administration group.Conclusion TFDM may inhibit doxorubicin-induced endothelial cell injury by activating VEGF-B/AMPKa pathway.
